BMC pregnancy and childbirth, 25(1), 2025
Abstract not indexed. Read at publisher
Topics
uterine entry technique chorioamniotic membrane separation, fetoscopic laser photocoagulation twin-to-twin transfusion, TTTS randomized controlled trial protocol, Burnett Munoz Belfort Nassr fetal surgery, Seldinger versus trocar uterine access fetoscopy, chorioamniotic membrane separation complication prevention, Baylor Texas Children Fetal Center twin surgery, minimally invasive fetal intervention technique comparison, membrane separation fetoscopy RCT BMC Pregnancy
PMID 41272584 41272584 DOI 10.1186/s12884-025-08410-5 10.1186/s12884-025-08410-5
Cite this article
Burnett, B. A., Munoz, J. L., Johnson, R. M., Parobek, C. M., Delgadillo Chabolla, L. E., Buskmiller, C., Donepudi, R. V., Sanz Cortes, M., Belfort, M. A., & Nassr, A. A. (2025). The effect of uterine entry technique on chorioamniotic membrane separation in fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome: protocol for a randomized controlled trial. BMC pregnancy and childbirth, 25(1). https://doi.org/10.1186/s12884-025-08410-5
Burnett BA, Munoz JL, Johnson RM, Parobek CM, Delgadillo Chabolla LE, Buskmiller C, et al. The effect of uterine entry technique on chorioamniotic membrane separation in fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome: protocol for a randomized controlled trial. BMC pregnancy and childbirth. 2025;25(1). doi:10.1186/s12884-025-08410-5
Burnett, B. A., et al. "The effect of uterine entry technique on chorioamniotic membrane separation in fetoscopic laser photocoagulation for twin-to-twin transfusion syndrome: protocol for a randomized controlled trial." BMC pregnancy and childbirth, vol. 25, no. 1, 2025.
Related articles
Research
Antiphospholipid syndrome in pregnancy: a comprehensive literature review
Murvai VR et al., 2025·BMC pregnancy and childbirth
Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombotic events and adverse obstetric outcomes, particularly in its obstetric form (OAPS). Affecting approximately 0.5% of the population, APS is a leading contributor to recurrent pregnancy loss (RPL), preeclampsia (PE), and fetal growth restriction ((FGR). Despite advancements in understanding its pathophysiology and management, optimal treatment strategies for APS in pregnancy remain challenging and require systematic evaluation. This review synthesizes current evidence on APS mechanisms, diagnostic criteria, and therapeutic interventions, with a focus on maternal and fetal outcomes in OAPS. A comprehensive search of PubMed, was conducted to identify studies exploring APS pathogenesis, diagnostic standards, and treatment efficacy in obstetric settings. Inclusion criteria prioritized randomized controlled trials, cohort studies, and systematic reviews with a clear focus on APS and pregnancy. The review confirmed that APS current accepted pathogenesis is governed by a "two-hit" model, where antiphospholipid antibodies (aPLs) initiate endothelial damage, culminating in thrombosis and placental insufficiency. Epidemiological analysis underscores the prevalence and severity of APS in obstetric contexts, with lupus anticoagulant (LA) emerging as a significant predictor of adverse outcomes. Evidence supports the use of low-dose aspirin (LDA) and heparin to reduce miscarriage rates, while adjunctive treatments, such as hydroxychloroquine (HCQ), have shown promise in improving live birth rates and reducing preterm delivery in high-risk cases. Emerging therapies, including tumoral necrosis factor (TNF-alpha) inhibitors and nitric oxide modulators, may offer additional benefits in refractory cases. APS remains a critical determinant of adverse pregnancy outcomes, necessitating precise diagnostic criteria and tailored management approaches. This systematic review emphasizes the importance of individualized therapeutic regimens to optimize maternal and fetal health in OAPS and highlights areas for future research, particularly regarding novel pharmacological approaches. Further studies are essential to refine treatment protocols and improve clinical guidelines for managing APS in pregnancy.
NaProTECHNOLOGYMenstrual Cycle
Open Access
Does a short luteal phase correlate with an increased risk of miscarriage? A cohort study
Duane M et al., 2022·BMC Pregnancy Childbirth
Miscarriage is defined as spontaneous loss of pregnancy prior to 20 weeks gestation. With an estimated risk of 15% of clinically confirmed pregnancies ending in miscarriage, it is the most common adverse event in pregnancy. Woman's age is the primary risk factor for miscarriage, while medical conditions, including hormonal abnormalities, are also associated. Progesterone is essential for maintaining pregnancy. A short luteal phase may reflect inadequate levels of progesterone production, but it is unclear whether a short luteal phase correlates with an increase in the risk of miscarriage. Using a cohort study design, we conducted a secondary data analysis from four cohorts of couples who used a standardized protocol to track biomarkers of the female cycles. A short luteal phase was defined as less than 10 days, with < 11, < 9, and < 8 days as alternate definitions in sensitivity analyses. We included women who experienced a pregnancy with a known outcome, identified the length of the luteal phase in up to 3 cycles prior to conception and assessed the relationship with miscarriage using a modified Poisson regression analysis, adjusting for demographic characteristics, smoking, alcohol use and previous pregnancy history. In our sample of 252 women; the overall miscarriage rate was 18.7%. The adjusted incident risk ratio of miscarriage in women who had at least one short luteal phase < 10 days, compared to those who had none, was 1.01 (95% CI: 0.57, 1.80) Similar null risk was found when assessing alternative lengths of short luteal phase. Women who had short luteal phases < 10 days in all 3 cycles prior to the conception cycle had an incident risk ratio of 2.14 (95% CI: 0.7, 6.55). Our study found that a short luteal phase in the three cycles prior to conception was not associated with higher rates of miscarriage in an international cohort of women tracking their cycles, but our sample size was limited. Further research to determine if short luteal phases or luteal phase deficiency is associated with early pregnancy losses among preconception cohorts with daily tracking of cycle parameters, in addition to progesterone and human chorionic gonadotropin levels, is warranted. Additionally, future studies should include women with recurrent short luteal phases as a more likely risk factor than isolated short luteal phases.
Research
Leukocyte telomere dynamics across gestation in uncomplicated pregnancies and associations with stress
Panelli DM et al., 2022·BMC pregnancy and childbirth
1. BMC Pregnancy Childbirth. 2022 May 2;22(1):381. 10.1186/s12884-022-04693-0. Leukocyte telomere dynamics across gestation in associations with stress. Panelli DM(1), Leonard SA(2), Wong RJ(3), Becker M(3)(4)(5), Mayo JA(3), Wu E(2), Girsen AI(2), Gotlib IH(6), Aghaeepour N(3)(4)(5), Druzin ML(2), GM(3), Stevenson DK(3), Bianco K(2). (1)Department of Obstetrics and Gynecology, Stanford University, 453 Road, Palo Alto, CA, 94304, USA. dpanelli@stanford.edu. (2)Department of Obstetrics and Gynecology, Stanford University, 453 Road, Palo Alto, CA, 94304, USA. (3)Department of Pediatrics, Stanford University, Stanford, CA, USA. (4)Department of Anesthesiology, Perioperative, and Pain Medicine, University, Stanford, CA, USA. (5)Department of Biomedical Data Science, Stanford University, Stanford, CA, USA. (6)Department of Psychology, Stanford University, Stanford, CA, USA. Short leukocyte telomere length stress and morbidity in non-pregnant adults. Little is known, however, maternal telomere dynamics in pregnancy. To address this, maternal leukocyte telomere length (LTL) during explored correlations with perceived stress. In this pilot study, maternal LTL was measured nulliparas who delivered live, term, singleton infants between 2012 and 2018 at a single institution. Participants were excluded hypertensive disease. Samples were collected over divided < 200/7 weeks (Timepoint 1); 201/7 to 366/7 weeks (Timepoint 2); and 370/7 to 9-weeks postpartum (Timepoint 3). participants also completed a survey assessing a perceived stress at the time of enrollment in the first trimester. measured using quantitative polymerase chain reaction (PCR). signed-rank tests were used to compare LTL differences across all timepoint intervals. To determine whether LTL, we compared postpartum Timepoint 3 LTLs vaginal versus cesarean birth. Secondarily, we evaluated assessed multivariate stress profile and LTL using machine learning analysis. A total of 115 samples from 46 patients were analyzed. LTL (mean ± SD), expressed as telomere to single copy gene (T/S) ratios, 1.15 ± 0.26, 1.13 ± 0.23, and 1.07 ± 0.21 for Timepoints 1, 2, and 3, respectively. were no significant differences in LTL between Timepoints 1 and 2 (LTL T/S change - 0.03 ± 0.26, p = 0.39); 2 and 3 (- 0.07 ± 0.29, p = 0.38) 1 and 3 (- 0.07 ± 0.21, p = 0.06). Participants significantly shorter postpartum LTLs than those who delivered vaginally (T/S 0.94 ± 0.12 cesarean versus 1.12 ± 0.21 vaginal, p = 0.01). analysis, poor sleep quality was the main stress shorter Timepoint 1 LTLs (p = 0.02) and shorter mean LTLs (p = 0.03). In this cohort of healthy pregnancies, significantly change across gestation and postpartum cesarean than after vaginal birth. Significant quality and short LTLs warrant further investigation. © 2022. The Author(s). 10.1186/s12884-022-04693-0 PMC9063069 35501726 [Indexed for MEDLINE] The authors declare interests.
RRM MethodsNaProTECHNOLOGYInfertility
Open Access
Restorative reproductive medicine for infertility in two family medicine clinics in New England, an observational study
Stanford JB et al., 2021·BMC Pregnancy Childbirth
Restorative reproductive medicine (RRM) seeks to identify and correct underlying causes and factors contributing to infertility and reproductive dysfunction. Many components of RRM are highly suitable for primary care practice. We studied the outcomes amongst couples who received restorative reproductive medicine treatment for infertility in a primary care setting. Two family physicians in Massachusetts trained in a systematic approach to RRM (natural procreative technology, or NaProTechnology) treated couples with infertility. We retrospectively reviewed the characteristics, diagnoses, treatments, and outcomes for all couples treated during the years 1989 to 2014. We compared pregnancy and live birth by clinical characteristics using Kaplan-Meier analysis. We employed the Fleming-Harrington weighted Renyi test or the logrank test to compare the cumulative proportion with pregnancy or with live birth. Among 370 couples beginning treatment for infertility, the mean age was 34.8 years, the mean prior time trying to conceive was 2.7 years, and 27% had a prior live birth. The mean number of diagnoses per couple was 4.9. Treatment components included fertility tracking with the Creighton Model FertilityCare System (80%); medications to enhance cervical mucus production (81%), to stimulate ovulation (62%), or to support the luteal phase (75%); and referral to female laparoscopy by a surgeon specializing in endometriosis (46%). The cumulative live birth rate at 2 years was 29% overall; this was significantly higher for women under age 35 (34%), and for women with body mass index < 25 (40%). There were 2 sets of twins and no higher-order multiple gestations. Of the 63 births with data available, 58 (92%) occurred at term. Family physicians can provide a RRM approach for infertility to identify underlying causes and promote healthy term live births. Younger women and women with body mass index < 25 are more likely to have a live birth.